PhD in clinical Research

Texila American University
Online

$ 2,500 - (Rs 1,70,640)
VAT incl.
You can also call the Study Centre
00 59... More
Students that were interested in this course also looked at...
See all

Important information

  • PhD
  • Online
  • Duration:
    Flexible
  • Online campus
  • Delivery of study materials
  • Support service
  • Personal tutor
  • Virtual classes
  • Examinations- physical attendance required
Description

International curriculum with all the latest updates in the field included
Students from over 30 Countries
Better carrier prospects especially in developing counties
Knowledge and skill development content included in the curriculum
Globally Valid , IAU Listed university offering the Degree
Well trained and expert faculty members
The unique scope to do article reviews and journal reviews where the selected cases will be published in international journal
Get employed in Clinical Research Organizations & Pharmaceutical companies that are in Clinical trials

Important information

Frequent Asked Questions

· Requirements

Doctoral(PhD) 60 credits: Duration: 3 years M.Sc (Clinical Research) /PG Degree in Medical and Allied Health Sciences / M.Sc in Life Science+ PG Diploma in Clinical Research students Doctoral(PhD) 75 credits Duration:3.5 years M.Sc in Life Science

What you'll learn on the course

Basic computer knowledge
Internet searching

Teachers and trainers (1)

 Dr.N.V.Naidu Doctor
Dr.N.V.Naidu Doctor
Dean for School of Clinical Research

Name Dr.N.V.Naidu Qualification B.Sc. (Vet)Osmania University, Hyderabad, India. M.S. Kansas State University, Manhattan, Kansas ,USA. Ph.D at Osmania University, Hyderabad, India. Designation Dean for School of Clinical Research

Course programme

Phase I trials
This is the first time the new drug is administered to a small number, around 20- 80 healthy, informed Volunteers under the close supervision of a doctor which may take several months to complete. The study is designed to determine the effects of the drug on humans including how it is absorbed, metabolized, and excreted. This phase also investigates the side effects that occur as dosage levels are increased. About 70% of experimental drugs pass this phase of testing. Phase II trials
In this phase, the medicine is administered to a group of approximately 100-300 patients to determine the efficacy of the drug. Most phase II studies are randomized trials where one group of patients receive the experimental drug, while a second "control" group receives a standard treatment or placebo. Often these studies are "blinded" which means that neither the patients nor the
researchers know who has received the experimental drug. This allows investigators to provide the comparative information about the relative safety and effectiveness of the new drug. About one-third of experimental drugs successfully complete both
Phase I and Phase II studies. Phase III trials
It involves randomized and blind testing in several hundred to several thousands of patients and can last for years; this provides a more thorough understanding of the effectiveness of the drug, the benefits and the possible adverse reactions if any. If the results are favorable, the data is presented to the licensing authorities for a commercial license. Phase IV trials
It is also called as Post Marketing Surveillance. This is a Surveillance operation phase after the drug has been approved for consumer sale. The main objectives at this stage is : (1) to compare a drug with other drugs already in the market; (2) to monitor a drug's long-term effectiveness and impact on a patient's quality of life; and (3) to determine the cost-effectiveness of a drug therapy relative to other traditional and new therapies. Phase IV studies can result in a drug being taken off the market or restrictions on use could be placed on the product depending on the findings in the study.

Additional information

The global pharmaceutical market is estimated at US$ 427 billion and Research & Development cost is estimated at US$ 60-65 billion annually. Two thirds of this amount is spent on Drug Development, ie, approximately US$ 40 billion. Clinical Trials involve almost 70% of time and money of new Drug Development. Cost of conducting Clinical Trials for a new drug is approximate US$ 200-250 million sometimes extending to $ 800 million

Students that were interested in this course also looked at...
See all